Nuvectis Pharma Files 8-K on Shareholder Votes
Ticker: NVCT · Form: 8-K · Filed: Jun 13, 2025 · CIK: 1875558
| Field | Detail |
|---|---|
| Company | Nuvectis Pharma, Inc. (NVCT) |
| Form Type | 8-K |
| Filed Date | Jun 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, sec-filing
Related Tickers: NVCT
TL;DR
NVCT filed an 8-K for shareholder votes. Keep an eye on outcomes.
AI Summary
Nuvectis Pharma, Inc. filed an 8-K on June 13, 2025, reporting on matters submitted to a vote of security holders as of June 12, 2025. The filing details the company's corporate structure, including its incorporation in Delaware and principal executive offices in Fort Lee, NJ. No specific voting outcomes or financial transactions are detailed in this excerpt.
Why It Matters
This filing indicates that Nuvectis Pharma held or is preparing to hold a vote of its security holders, which could pertain to significant corporate actions or governance changes.
Risk Assessment
Risk Level: low — The filing is procedural, reporting on a shareholder vote without immediate financial implications or significant new information.
Key Players & Entities
- Nuvectis Pharma, Inc. (company) — Registrant
- June 12, 2025 (date) — Date of earliest event reported
- June 13, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of Incorporation
- Fort Lee, NJ (location) — Principal Executive Offices
FAQ
What specific matters were submitted to a vote of Nuvectis Pharma's security holders?
This excerpt of the 8-K filing does not specify the exact matters submitted for a vote, only that such a submission occurred as of June 12, 2025.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on June 12, 2025.
What is Nuvectis Pharma's principal executive office location?
Nuvectis Pharma's principal executive offices are located at 1 Bridge Plaza, Suite 275, Fort Lee, NJ 07024.
In which state was Nuvectis Pharma, Inc. incorporated?
Nuvectis Pharma, Inc. was incorporated in Delaware.
What is the SEC file number for Nuvectis Pharma, Inc.?
The SEC file number for Nuvectis Pharma, Inc. is 001-41264.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 13, 2025 regarding Nuvectis Pharma, Inc. (NVCT).